PHILADELPHIA – Troutman Pepper Locke advised Cagent Vascular, Inc., a leader in endovascular technologies, in the closing of a $41 million Series D financing round. The financing supports clinical advancement and commercialization of the company’s dual-modality intravascular lithotripsy platform, with proceeds funding the peripheral commercial launch and coronary program development. For more information, see the press release.
Troutman Pepper Locke has represented Cagent Vascular since its formation in 2014. The company also participated in Troutman SEED™, the firm’s unique program that supports startups and early-stage emerging companies.
The Troutman Pepper Locke team that represented Cagent Vascular was led by Chris Miller, Stephen Fox, Emily Makar, and Dawn Hall.
The firm’s leading Health Care and Life Sciences Practice encompasses the entire spectrum of health care and life sciences companies. The team collaborates across disciplines to solve complex legal challenges confronting clients, offering a full suite of corporate, intellectual property, regulatory, and litigation services. Few law firms have a comparable health care and life sciences practice, and Troutman Pepper Locke draws on its deep industry knowledge to provide the precise, holistic advice and guidance clients need throughout their business cycles.
Troutman Pepper Locke is very active in the emerging company and venture capital communities, advising clients through every stage of their life cycle, from formation through financing and growth, and their eventual merger, acquisition, or IPO exit. For select companies, the firm also offers the unique Troutman SEED™ program. This development program combines the resources of an experienced, multidisciplinary team into an affordable package for startups, early-stage, and fast-growing companies, providing them with comprehensive legal counsel, mentoring, relationship-building opportunities, and more.
Troutman Pepper Locke
Troutman Pepper Locke helps clients solve complex legal challenges and achieve their business goals in an ever-changing global economy. With more than 1,600 attorneys in 30+ offices, the firm serves clients in all major industry sectors, with particular depth in energy, financial services, health care and life sciences, insurance and reinsurance, private equity, and real estate. Learn more at troutman.com.